ArticleJournal of the American Society of Nephrology : JASN2017

Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model.

Ming-Zhi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.